203 related articles for article (PubMed ID: 29037928)
1. Melanoma of the Foot Is Associated With Advanced Disease and Poorer Survival.
Adams BE; Peng PD; Williams ML
J Foot Ankle Surg; 2018; 57(1):52-55. PubMed ID: 29037928
[TBL] [Abstract][Full Text] [Related]
2. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
[TBL] [Abstract][Full Text] [Related]
3. Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome.
Sanlorenzo M; Osella-Abate S; Ribero S; Marenco F; Nardò T; Fierro MT; Novelli M; Cervetti O; Bernengo MG; Quaglino P
Int J Dermatol; 2015 Sep; 54(9):1023-9. PubMed ID: 25660506
[TBL] [Abstract][Full Text] [Related]
4. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
5. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Zappalà A; Capuano M; Bono R; Nudo M; Marino C; Michelozzi P
Am J Surg; 2016 Nov; 212(5):935-940. PubMed ID: 27266393
[TBL] [Abstract][Full Text] [Related]
6. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and Management of Thick and Ultrathick Melanoma.
Blakely AM; Cohen JT; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2019 Nov; 42(11):824-829. PubMed ID: 31517636
[TBL] [Abstract][Full Text] [Related]
8. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
9. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
11. Foot Melanoma Localized to Subungual Toe Location Portends Poorer Prognosis.
Williams ML; Parupia Y; King CM; Dobbs TG; Peng P
J Foot Ankle Surg; 2023; 62(5):840-844. PubMed ID: 37169120
[TBL] [Abstract][Full Text] [Related]
12. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node status predicts survival in thick melanomas: the Oxford perspective.
Rughani MG; Swan MC; Adams TS; Marshall A; Asher R; Cassell OC; Middleton MR
Eur J Surg Oncol; 2012 Oct; 38(10):936-42. PubMed ID: 22617251
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in patients with mucosal melanomas.
Keller DS; Thomay AA; Gaughan J; Olszanski A; Wu H; Berger AC; Farma JM
J Surg Oncol; 2013 Dec; 108(8):516-20. PubMed ID: 24132665
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
17. Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.
Hocevar M; Dragonja Z; Pilko G; Gazic B; Zgajnar J
Eur J Surg Oncol; 2014 Oct; 40(10):1271-5. PubMed ID: 24656456
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in thick malignant melanoma: A 16-year single unit experience.
Hunger RE; Michel A; Seyed Jafari SM; Shafighi M
Eur J Dermatol; 2015; 25(5):472-6. PubMed ID: 26394835
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
